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Purpose. Depression is currently the leading cause of illness and disability in young
people. Evidence suggests that behavioural activation (BA) is an effective treatment for
depression in adults but less research focuses on its application with young people. This
review therefore examined whether BA is effective in the treatment of depression in
young people.
Methods. A systematic review (International Prospective Register of Systematic
Reviews reference: CRD42015020453), following Preferred Reporting Items for
Systematic Reviews and Meta-Analyses guidelines, was conducted to examine studies
that had explored behavioural interventions for young people with depression. The
electronic databases searched included the Cochrane Library, EMBASE, MEDLINE,
CINAHL Plus, PsychINFO, and Scopus. A meta-analysis employing a generic inverse
variance, random-effects model was conducted on the included randomized controlled
trials (RCTs) to examine whether there were overall effects of BA on the Children’s
Depression Rating Scale – Revised.
Results. Ten studies met inclusion criteria: three RCTs and seven within-participant
designs (total n = 170). The review showed that BA may be effective in the treatment of
depression in young people. The Cochrane risk of bias tool and the Moncrieff scale used
to assess the quality of the included studies revealed a variety of limitations within each.
Conclusions. Despite demonstrating that BA may be effective in the treatment of
depression in young people, the review indicated a number ofmethodological problems in
the included studies meaning that the results and conclusions should be treated with
caution. Furthermore, the paucity of studies in this area highlights the need for further
research.
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Practitioner points
 Currently BA is included within National Institute for Health and Clinical Excellence (NICE, 2009)
guidelines as an evidence-based treatment for depression in adults with extensive research
supporting its effectiveness. It is important to investigate whether it may also be effective in treating
young people.
 Included studies reported reductions in depression scores across a range of measures following BA.
 BA may be an effective treatment of depression in young people.
By the year 2030, depression will be the leading cause of disease burden globally; it is
already the leading cause of illness and disability in young people (World Health
Organization [WHO, 2013, 2014]). In a large meta-analysis (Costello, Erkanli, & Angold,
2006), the overall prevalence rates of depression were suggested to be 2.8% for children
under 13 years of age and 5.7% for those aged between 13 and 18 years. It is important
that young people experiencing depressive episodes are identified early and receive
effective treatment to reduce negative symptoms and improve mood. Such treatments
may assist young people to deal with the impact of their depression (i.e., on their family,
social, and academic functioning) and reduce the likelihood or impact of future episodes
(Birmaher & Brent, 2007).
However, despitehighratesof depressivedisorders, fewyoungpeople seekhelp (O’Dea,
Calear, & Perry, 2015; Rickwood, Deane, Wilson, & Ciarrochi, 2005). This limited help-
seekingmay be influenced by factors associatedwith treatments including stigma (Gulliver,
Griffiths,&Christensen,2010;Rickwood et al., 2005), negative attitudes abouthelp-seeking
(Rickwood et al., 2005), accessibility (Gulliver et al., 2010), and young people’s reluctance
to engage one-to-one with a therapist (Rickwood, 2010). Of those who do seek help, few
receive it from specialist mental health services (Richardson, Stallard, & Velleman,2010),
often as a result of limited clinician capacity and therapy availability (Roberts, 2013).
Increasing activity can be an important component in reducing depressive thoughts
and feelings (Lejuez, Hopko, Le Page, Hopko, & McNeil, 2001). Behavioural activation
(BA), a type of talking therapy focused on increasing adaptive activities, can be defined as
a structured, brief psychotherapeutic approach that aims to (1) increase engagement in
adaptive activities (which often are those associated with the experience of pleasure or
mastery), (2) decrease engagement in activities that maintain depression or increase risk
for depression, and (3) solve problems that limit access to reward or that maintain or
increase aversive control’ (Dimidijian, Barrera, Martell, Munoz, & Lewisohn, 2011, p. 4).
According to Dimidijian et al. (2011), BA is defined by its reliance on behavioural
principles with a specific focus on behaviour change. Several terms have been used to
describe this type of treatment. In this study, the term ‘BA’ is used to encompass all
therapies based upon this broad behavioural approach to the treatment of depression
regardless of the specific terms used to describe the intervention.
Multiple studies have demonstrated the effectiveness of face-to-face BA in the
treatment of depression in adults. Ekers, Richards, and Gilbody (2008) in a meta-analysis
of 17 studies found BA to be significantly superior to control conditions, brief
psychotherapy and supportive therapy and comparable to CBT in its effectiveness for
ameliorating symptoms of depression. Cuijpers, Van Straten, and Wamerdam (2007)
found BA to be as effective as cognitive therapy, and Mazzuchelli, Kane, and Rees (2009)
found a large effect size in favour of BA over controls. A systematic review (Chartier &
Provencher, 2013) of studies (n = 21) comparing the efficacy of BA in treating depression
to other psychotherapeutic andpharmacological interventions found BA to be as effective
as other psychotherapies including cognitive behavioural therapy (CBT). This also
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provides some evidence that BA may be effective when delivered in a low intensity form
(e.g., guided self-help).
Although treatment recommendations and guidelines for individuals experiencing
depression differ between adults and young people, given the extensive research
supporting the use of BA with adults it is important to investigate whether it may also be
effective in treating young people.
There has been less research on the use of BA with children and young people.
Research in this area has generally been in the form of case series with small sample sizes,
for example Chu, Colognori,Weissman, and Bannon (2009; n = 5);Wallis, Roeger, Milan,
Walmsley, and Alison (2012;n = 5). Both of these reviews provided support for the use of
BA in the treatment of young people with depression and/or anxiety, finding high
treatment satisfaction and clinical benefits including symptom reductions. Similar results
were obtained in a pilot, uncontrolled study of the use of BA for treating depressed young
people in rural Australia (Jacob, Keeley, Ritschel, &Craighead, 2013),with all participants
(n = 5) showing reduced levels of depressive symptoms between baseline and
completion (at 6 months).
Given the paucity of research in this area and the lack of any published systematic
review, an examinationof BA for usewith children and youngpeople is required and timely
(Chartier & Provencher, 2013). Young people experiencing depression may be treated
more effectively using computerized therapies which have increased availability and
accessibility (Stallard, Velleman, & Richardson, 2010), less stigma and are presented in a
format attractive tomanyyoungpeople compared to traditional face-to-face therapies. Thus
far, much research has focused on the delivery of CBT in this form (e.g., Abeles et al., 2009;
Spence, Holmes, March, & Lipp, 2006; Spence et al., 2008; Wright et al., 2014), with
computerized CBT (CCBT) representing an alternative form of therapy delivery that can be
administered at a lower cost than traditional treatments (Merry et al., 2012). Although adult
research has also often focused upon CCBT for depression, research into computerized BA
has started to emerge. In a review by Spates et al. (2016), five web-based BA interventions
were identified all of which have demonstrated relative success in initial pilot trials.
Research is therefore required to establish whether BA in a computerized format has
been used with young people experiencing depression also and, if so, whether it is an
effective treatment.
This review sought to investigate (1) whether BA is effective in the treatment of
depression in young people and, if so, (2) whether it can be effectively delivered in a
computerized form.
Methods
This review was completed with reference to the guidelines reported in the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Liberati
et al., 2009). The review protocol was registered on the International Prospective
Register of Systematic Reviews (PROSPERO), an online database for systematic review
protocols (reference: CRD42015020453).
Information sources and study identification
The following electronic databases were searched between July and August 2015:
Cochrane Library, EMBASE, MEDLINE, CINAHL Plus (EBSCO), PsychINFO, Scopus, and
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the ISCRTN registry. To cover peer review and grey literature sources, the Health
Management Information Consortium, NHS evidence, Open Grey, the Networked Digital
Library of Theses and Dissertations,Web of Science Conference Proceedings, and ZETOC
were searched with the search simplified accordingly. The reference lists of all included
studies were examined and forward citation searching carried out in Google Scholar. No
restrictions on publication status or language were imposed.
Titles and abstracts were screened independently by the primary researcher alongside
a second reviewer to enhance the reliability of included studies. If any disagreements
occurred between the two researchers, the two met to discuss these. In the event that a
decision could not be reached between the two, a third researcher was consulted and
asked to screen the disagreed paper(s) and make an overall decision regarding selection.
The search strategy used was based on three main constructs: behavioural
interventions (including BA, behavioural therapy, behavioural interventions, self-
monitoring, and activity scheduling), depression (including depressive disorder, depres-
sive, depression, and depressed) and young people (including adolescents, children, teen,
youth, juvenile, pre-pubescent, and student). See Appendix for the search strategy used.
Eligibility criteria
Thepopulation of interest was young people aged 18 years and below. Studies employing
a population that crossed the age of 18 were included if a minimum of 90% of the sample
was under 18. Trial participants had to be experiencing depression or depressive
symptoms as established by a validated screening measure or diagnosis based on a
structured clinical interview conducted to internationally recognized standards (e.g.,
International Classification of Disease, Diagnostic Statistical Manual).
For inclusion, interventions had to be based upon either operant conditioning
principles or comprise techniques fundamental to behavioural treatments of depression
(activity scheduling, self-monitoring, goal setting). Interventions based on third-waveCBT
principles (e.g., acceptance and commitment therapy) were excluded.
No restrictions were placed on comparator or control group types to avoid excluding
any relevant studies reporting on BA. Studies that did not employ a control group were
also included.
The primary outcome measure was levels of depression/depressive symptoms as
measured by validated assessments. Assessments could include self-report measures and
clinician or researcher administrated ratings. Additional outcomes included levels of
anxiety symptoms (measured by validated assessments), cost-effectiveness, quality of life,
and school attendance.
Randomized controlled trial (RCT) and pre-/post-study designs presenting relevant
outcomes in a useable format were included in the review.
No restrictions were placed on intervention duration, delivery settings (e.g.,
community, health care, educational), or delivery mode (e.g., computerized, face-to-
face), the timings of the measurement of the outcomemeasures nor upon sample sizes or
sampling methodologies.
Data extraction
Information extracted (using a pre-piloted proforma) from included studies comprised
study characteristics (study name, author(s), year of publication/production (if unpub-
lished), study location, and setting), study design, study populations (basic demographics
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of participants, depression diagnosis methods), intervention details and comparators
(intervention type, comparator, duration of the intervention, number of sessions), and
relevant outcome data for effect size calculations (depression severity, unit of
measurement).
Quality assessments
Themethodological quality of RCTs was formally assessed using the Cochrane risk of bias
tool (Higgins et al., 2011), a general tool used to assess risk in any RCT and the Moncrieff
scale (Moncrieff, Churchill, Drummon, & McGuire, 2001), specifically designed to assess
the quality of controlled studies examining interventions for depressive and non-
psychotic symptoms. The Cochrane risk of bias tool categorises risk as ‘high’, ‘low’, or
‘unclear’ (where insufficient information is supplied to assess level of risk), whilst the
Moncrieff scale awards scores (0–2) based on a study’s success at addressing 23 risk items
with higher scores representing higher levels of quality.
The inclusion of both scales allowed comparisons to be made between a general
quality assessment tool and one specifically designed for use within the proposed field.
The Moncrieff scale was also used to assess the quality of within-participant design
studies.
Data synthesis and statistical analysis
A summary of the outcome measures of all included studies is provided alongside a forest
plot providing a graphical display of the study outcomes of the RCTs.Owing to the limited
number of RCTs, only one meta-analysis was conducted for the Children’s Depression
Rating Scale – Revised (CDRS-R; Poznanski & Mokros, 1996). Studies were pooled using
the generic inverse variance method with a random-effects model. All analyses were
undertaken in stata version 13 (Stata Corporation, 2013). Statistical heterogeneity was
assessed using the I2 statistic with a value of 25% being regarded as low, 50% as moderate,
and 75% as high (Higgins, Thompson, Deeks, & Altman, 2003). Publication bias could not
be examined due to insufficient numbers of included studies.
Results
Literature search results
The original search, including grey literature searching, identified 5,931 potentially
relevant records of which 5,495 remained after duplicates (n = 436) were removed.
No additional studies were found from forward citation searches. The screening of
titles and abstracts was undertaken by the primary and secondary reviewer who
identified 42 full-text articles for assessment. No disagreements as to studies eligible for
inclusion occurred. After relevance checking was independently conducted, 10 papers
were deemed eligible for inclusion (Figure 1). Reasons for exclusion of the other 32
included <90% of the sample aged 18 or below (n = 13; Armento, 2011; Armento,
McNulty, & Hopko, 2012; Gawrysiak, Nicholas, & Hopko, 2009; Harmon, Nelson, &
Hayes, 1980; Levin et al., 2010; Ly et al., 2014; Mohammadi, Birashk, & Gharaie, 2013;
Moradveisi, Huibers, Renner, Arasteh, & Arntz, 2013; Parker et al., 2011; Proudfoot
et al., 2013; Shaw, 1977; Takagaki et al., 2013; Velayudhan, Gayatridevi, & Bhat-
tacharjee, 2010), treatments not meeting the criteria to be regarded as BA (n = 15;
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Bilek & Ehrenreich-May, 2012; Brent, Kolko, Birmaher, Baugher, & Bridge, 1999; Brent
et al., 1997, 1998; Chu, Hoffman, Johns, Reyes-Portillo, & Hansford, 2015; Dundon,
2010; Esposito, 2005; Ettelson, 2003; Kauer et al., 2011; Landback et al., 2009; Merry,
McDowell, Wild, Bir, & Cunliffe, 2004; Nystedt, 1977; Reid et al., 2011; Sobowale
et al., 2013; Van Voorhees et al., 2008), being an ongoing study with currently
unreported results (n = 1; C. E. W. Kitchen, D. Ekers, P. A. Tiffin, & S. Lewis, Personal
communication) or examining a sample which had not received a diagnosis of
depression at baseline (n = 3; Davidson et al., 2014; Pass, Brisco, & Reynolds, 2015;
Reynolds, Macpherson, Tull, Baruch, & Lejuez, 2011).
Characteristics of included studies
Of the ten studies that met inclusion criteria for the review, three were RCTs (Chu et al.,
2016;McCauley et al., 2015; Stark, 1985) and seven used awithin-participant design (Chu
et al., 2009; Douleh, 2013; Jacob et al., 2013; Riley & Gaynor, 2014; Ritschel, Ramirez,
Jones, & Craighead, 2011; Wallis et al., 2012; Weersing, Gonzalez, Campo, & Lucas,
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses diagram.
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2008). The studies varied greatly regarding sample sizes, settings, participant demo-
graphics, and the interventions and comparators (if applicable) employed. Overall, 170
participants were included across the ten studies ranging in age from 8 to 18 years.
The majority of studies (n = 7) measured depression using the Children’s CDRS-R
(Poznanski & Mokros, 1996). The CDRS-R is the most widely used measure of child and
adolescent depression severity and demonstrates high inter-rater reliability (Pozanski and
Mokros: a = .92), good 2-week test–retest reliability (.80), and good to excellent internal
consistency (a = .74–.92) within this context (Mayes, Bernstein, Haley, Kennard, &
Emslie, 2010).
Five of the ten studies also collected outcome data relating to anxiety, whilst only one
reported on quality of life. None of the other secondary outcomes of interest, cost-
effectiveness, and school attendance was reported in any of the studies. Table 1 provides
a summary of the descriptive characteristics of the included studies.
Quality assessments
Randomized controlled trials
On the Cochrane risk of bias tool (Table 2), all three RCTs demonstrated low risk
regarding the reporting of other sources of bias, incomplete outcome data, and blinding
outcome assessors. Level of bias was unclear where no, or insufficient, information
regarding a particular domain (allocation concealment (Chu et al., 2016; Stark, 1985),
random sequence generation; Stark, 1985) was provided. In addition, with no pre-
published protocols, it was hard to determine whether all pre-specified outcomes had
been reported in each of the three RCTs and therefore the level of bias due to selective
reporting was unclear. As the three RCTs involved the delivery of BA neither participants
nor personnel could be blinded to treatment allocation. However, a lack of blindingmeant
that all three RCTs demonstrated a high risk of bias on this domain.
On the Moncrieff scale (Table 3), all three RCTs attained maximum quality scores for
method of allocation, providing clear descriptions of treatment, using clear diagnostic
criteria and the recording of exclusion criteria. However, on a number of the domains
examined, although bias was minimized, it was still present (e.g., in conducting
appropriate statistical analyses and assessment of compliance to treatments). High risk of
bias was reported where studies provided no or insufficient information about power
calculations, concealment of allocation (Chu et al., 2016; Stark, 1985), sample sizes, and
declarations of interest (Stark, 1985). Only the study by Chu et al. (2016) attained a
maximum score for reporting side effects, with neither of the other two RCTs discussing
this.
Within-participant designs
Only one domain on theMoncrieff scale (Table 4) attained amaximumquality score on all
seven included studies. This related to the outcome measures used with all studies using
validated and reliable instruments. However, none of the studies conducted power
calculations, blinded assessors, employed adequate sample sizes, or reported any
information about the side effects of treatment. As a result, every study was awarded zero
suggesting the presence of bias on each of these domains. For the remainder of bias
domains on the Moncrieff scale, most studies attained a score of one or two suggesting
measures had been taken to minimize the level of bias. However, a number of studies
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Table 1. A descriptive summary of the characteristics of included studies (n = 10)
Study Subjects Setting
Study
design Intervention Comparator
Outcome
measures
Data
collection
points
Chu et al.
(2016)
USA
35 young people (10 males,
25 females), aged 12–14
(mean: 12.03) with a
current clinical principal
diagnosis of either a unipolar
depression disorder or an
anxiety disorder based on
CDRS-R or ADIS-IV
One public
middle
school
RCT 10 one-hour sessions
of group behavioural
activation therapy
(GBAT)
Delivered face-to-
face (1 clinical
psychologist, 4
graduate students,
2 school counsellors)
N = 21 (intention to
treat – 2 lost to
follow-up)
Wait list control
N = 14 (intention
to treat – 1 lost
to follow-up)
CDRS-R
CES-D
ADIS-IV
SCARED
Pre-treatment
Post-treatment
4-month follow-up
McCauley
et al. (2015)
USA
60 young people (38 females,
22 males), aged 12–18 (mean:
14.9) with a depressive
disorder based on the K-SADS
diagnostic interview
One
hospital-based
mental health
clinic
RCT 14 sessions of
adolescent behavioural
activation program
(A-BAP)
Delivered face-to-face
(2 doctoral students, 1
social worker)
N = 35 (intention to
treat – 8 lost to follow-up)
Up to 14
sessions of a
face-to-face
delivered,
evidence-based
practice for
depression
N = 25
(intention to
treat – 9 lost
to follow-up)
K-SADS
diagnostic
interview
CDRS-R
SMFQ
MASC
Pre-treatment
Post-treatment
6-month follow-up
12-month follow-up
Stark (1985)
USA
29 young people (16 males and
13 females) aged 9–12 (mean:
11.2) with a depressive disorder
based on the CDI (≥16)
One
elementary
school
RCT 12 45-minute sessions of
behaviour therapy delivered
over 5 weeks
Delivered face-to-face (1
study therapist, 1 clinical
psychologist)
N = 10, 9 included in analysis
Twelve 45 minute
sessions of
face-to-face
delivered
self-control
therapy over
5 weeks or wait
list control
CDI
CDS
CDRS-R
RCMAS
Pre-treatment
Post-treatment
8-week follow-up
Continued
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Table 1. (Continued)
Study Subjects Setting
Study
design Intervention Comparator
Outcome
measures
Data
collection
points
N = self-control
therapy: 9 (all
included in
analysis, wait list:
9 (all included in
analysis)
Riley and
Gaynor
(2014)
USA
11 participants (9 males and 2
females) aged 8–12 (mean: 9.8)
with a depressive disorder as
based upon scores on the
CDRS-R (≥12) and CDI (≥40)
3 elementary
schools, 1
middle
school
Within-
participant
design
3 sessions of face-to-face
delivered non-directive
therapy (NDT) only over
3 weeks:
N = 4, all included in the
analysis
or
3 sessions of face-to-face
delivered non-directive
therapy (NDT) over
3 weeks:
Followed by 9 sessions of
behaviour therapy (BT)
None CDRS-R
CDI
FQOLS
Pre-treatment
Post-treatment
(both groups)
2-month follow-up
Douleh
(2013)
USA
14 participants (8 males and 6
females) aged 14–18 (mean:
15.7) with a depressive
disorder based upon scores
on the CDRS-R (≥45)
2 High
schools
Within-
participant
design
1–4 sessions of Motivational
Interviewing (MI) over
4 weeks
Delivered face-to-face
(study therapist)
N = 14 (2 lost to
follow-up)
or
1–4 sessions of MI and 1–4
sessions of Fun activities
(FA)
None CDRS-R
BDI-II
MINI-KID
HRQOL
(measure not
specified)
A1: Pre-treatment
A2: Post-MI (4 weeks
after pre-treatment)
A3: Post-FA (10 weeks
after pre-treatment)
A4: Post-VBBA
(16 weeks after
pre-treatment)
A5: 20 weeks after
pre-treatment
Continued
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Table 1. (Continued)
Study Subjects Setting
Study
design Intervention Comparator
Outcome
measures
Data
collection
points
Delivered face-to-face
(study therapist)
N = 7 (3 lost to follow-up)
or
1–4 sessions of MI, 1–4
sessions of FA and 1–4
sessions of
values-based behavioural
activation (VBBA)
Delivered face-to-face (study
therapist)
N = 1 (1 included in analysis)
Ritschel et al.
(2011)
USA
6 young people (3 males and
3 females) aged 14–17 with
a depressive disorder based
on the K-SADS or CDRS-R
(≥45)
Outpatient
adolescent
mood clinic
Within-
participant
design
22 sessions of behavioural
activation delivered over 18
weeks
Delivered face-to-face (2
doctoral level staff, 1 graduate
student)
N = 6 (all included in analysis)
None KSADS
CDRS-R
BDI-II
Pre-treatment
Post-treatment
Chu et al.
(2009)
USA
5 young people (2 males and 3
females) aged 12–14 with a
current clinical principal
diagnosis of either a unipolar
depression disorder or an
anxiety disorder based on
CES-D (≥15) or ADIS-IV
(no cut-offs specified)
One public
middle
school
Within-
participant
design
13 sessions of group behavioural
activation therapy (GBAT)
delivered over 13 weeks
Delivered face-to-face (mental
health specialists)
N = 5 (all included in analysis)
None CES-D
ADIS-IV
MASC
Pre-treatment
Post-treatment
(13 weeks)
Wallis et al.
(2012)
Australia
5 participants (all female)
aged 14–15 with a diagnosis
of a depressive disorder
based upon the CES-D (no
cut-offs specified)
Local mental
health service
Within-
participant
design
10 sessions of behavioural
activation delivered over 10
weeks
Delivered face-to-face (2 social
None BDI-II Pre-treatment
2 weeks
3 weeks
6 weeks
Continued
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Table 1. (Continued)
Study Subjects Setting
Study
design Intervention Comparator
Outcome
measures
Data
collection
points
workers) and work books
N = 5 (all included in analysis)
Completion
(10 weeks)
Weersing
et al. (2008)
USA
2 participants (1 male and 1
female) aged 13 and 17 with
a depressive disorder based
on CDI (≥13) or an anxiety
disorder based on the
SCARED (≥25)
Primary
care
practice
Within-
participant
design
8 30-minute sessions of Integrated
brief behavioural therapy for
anxiety and depression delivered
over 12 weeks
Delivered face-to-face (mental
health specialists)
N = 2 (all included in analysis)
None CDI
K-SADS
SCARED
Pre-treatment
Post-treatment
(12 weeks)
24-week follow-up
Jacob et al.
(2013)
USA
3 participants (2 males and 1
female) aged 14–17 with a
depressive disorder based
on K-SADS, CDRS-R (≥45)
and BDI-II (≥14)
Community
mental
health
clinics
Within-
participant
design
14–17 sessions of behavioural
activation (adapted for
low-income, African American
adolescents) delivered over 6
months
Delivered face-to-face (3 study
therapists)
N = 3 (all included in analysis)
None KSADS
CDRS-R
BDI-II
Pre-treatment
At each session (BDI-II)
Week 9 (CDRS-R)
Post-treatment
(6 months)
Notes. Depression measures: CDRS-R, Children’s Depression Rating Scale – Revised (Poznanski & Mokros, 1996); SMFQ, Short Mood and Feelings Questionnaire
(Angold, Costello, Messer, & Pickles, 1995); CES-D, Center for Epidemiologic Studies Depression Scale (Radloff, 1977); CDI, Children’s Depression Inventory
(Kovacs, 2011); CDS, Children’s Depression Scale (Reynolds, 1980); BDI-II, Beck Depression Inventory (Beck, Steer, & Brown, 1996); K-SADS, Kiddie Schedule for
Affective Disorders (Kaufman et al., 1997); MINI-KID, Mini International Neuropsychiatric Interview for Children and Adolescents (Sheehan et al., 2010). Anxiety
measures: MASC,Multi-Dimensional Anxiety Scale for Children (March, Parker, Sullivan, Stallings, &Conners, 1997); SCARED, Screen for Anxiety Related Emotional
Disorders (Birmaher et al., 1999); RCMAS, RevisedChildren’s Manifest Anxiety Scale (Reynolds & Richmond, 1978); ADIS-IV, Anxiety Disorders Interview Schedule
for DSM-IV Child Interview (Silverman & Albano, 1996). Quality of life measures: FQOLS, The Family Quality of Life Scale–Family Interactions Subscale (Hoffman,
Marquis, Poston, Summers, & Turnbull, 2006). RCT, randomized controlled trials.
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Table 3. Moncrieff scale – included randomized controlled trials (RCTs) (n = 3)
Domain
RCTs
McCauley et al. (2015) Chu et al. (2016) Stark (1985)
Objections and specifications,
main outcomes a priori
1 2 2
Adequate sample size 2 2 0
Appropriate duration of trial and
follow-up
2 2 1
Power calculations 2 0 0
Method of allocation 2 2 2
Concealment of allocation 2 0 0
Clear description of treatments 2 2 2
Blinding of subjects N/A N/A N/A
Sources of subjects/representative
sample
1 2 2
Use of diagnostic criteria 2 2 2
Record of exclusion criteria 2 2 2
Description of sample demographics 1 2 2
Blinding of assessor 1 2 1
Assessment of compliance with
treatments
1 1 1
Details of side effects 0 2 0
Record of number and reasons for
withdrawal
2 1 2
Outcome measures described clearly 2 2 2
Information on comparability and
adjustment for difference in analysis
2 1 2
Inclusion of all subjects in analysis (ITT) 2 2 2
Presentation of results with inclusion of
data for re-analysis of main outcomes
2 2 2
Appropriate statistical analysis 1 1 1
Conclusions justified 2 2 2
Declarations of interest 2 2 0
Total 36 36 30
Notes. Maximum total score is 56; higher scores denote lower bias.
Table 2. Cochrane risk of bias and included randomized controlled trials (n = 3)
Domain McCauley et al. (2015) Chu et al. (2016) Stark (1985)
Random sequence generation + + ?
Allocation concealment + ? ?
Selective reporting ? ? ?
Other sources of bias + + +
Blinding participants and personnel   
Blinding (outcome assessment) + + +
Incomplete outcome data + + +
Notes. ‘+’ low risk of bias; ‘’ high risk of bias; ‘?’ unknown risk of bias.
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Table 4. Moncrieff scale – within-participant design studies (n = 7)
Domain
Within-participant designs
Chu et al.
(2009)
Jacob
et al.
(2013)
Ritschel et al.
(2011)
Wallis et al.
(2012)
Weersing et al.
(2008)
Douleh
(2013)
Riley and
Gaynor (2014)
Objections and specifications,
main outcomes a priori
2 1 1 1 1 2 2
Adequate sample size 0 0 0 0 0 0 0
Appropriate duration of trial and
follow-up
1 1 1 0 2 1 0
Power calculations 0 0 0 0 0 0 0
Method of allocation N/A N/A N/A N/A N/A N/A N/A
Concealment of allocation N/A N/A N/A N/A N/A N/A N/A
Clear description of treatments 2 2 2 0 2 2 2
Blinding of subjects N/A N/A N/A N/A N/A N/A N/A
Sources of subjects/representative
sample
1 1 1 1 1 1 1
Use of diagnostic criteria 1 2 2 1 1 2 2
Record of exclusion criteria 1 2 2 1 1 2 2
Description of sample demographics 2 2 2 0 2 2 2
Blinding of assessor 0 0 0 0 0 0 0
Assessment of compliance with
treatments
2 2 2 0 0 1 2
Details of side effects 0 0 0 0 0 0 0
Record of number and reasons for
withdrawal
2 2 2 2 0 1 1
Outcome measures described clearly 2 2 2 2 2 2 2
Information on comparability
and adjustment
for difference in analysis
0 0 0 0 0 1 1
Continued
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A
for
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young
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Table 4. (Continued)
Domain
Within-participant designs
Chu et al.
(2009)
Jacob
et al.
(2013)
Ritschel et al.
(2011)
Wallis et al.
(2012)
Weersing et al.
(2008)
Douleh
(2013)
Riley and
Gaynor (2014)
Inclusion of all subjects in
analysis (ITT)
2 2 2 0 0 2 2
Presentation of results with
inclusion of data
for re-analysis of main outcomes
1 1 1 0 0 1 1
Appropriate statistical analysis 0 0 1 0 0 1 1
Conclusions justified 2 2 2 0 2 1 2
Declarations of interest 0 0 0 0 0 0 2
Total 21 22 23 8 14 22 25
Notes. Maximum total score is 56; higher scores denote lower bias.
1
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attained scores of zero in relation to the following: bias related to statistical analyses (Chu
et al., 2009; Jacob et al., 2013; Wallis et al., 2012; Weersing et al., 2008), not providing
information on comparability and adjustment for differences in analyses (Chu et al., 2009;
Jacob et al., 2013; Ritschel et al., 2011; Wallis et al., 2012; Weersing et al., 2008), not
reporting compliance and treatment adherence (Wallis et al., 2012; Weersing et al.,
2008), and having a limited follow-up period (Riley & Gaynor, 2014; Wallis et al., 2012).
Through not employing a randomized methodology, two items on the Moncrieff scale
(methods of allocation and concealment of allocation) were not applicable to the within-
participant designs.
BA effectiveness and depression
The effectiveness of BA is reported separately for each of the two types of study designs
included in the review (RCTs,within-participant designs).Owing to the limited number of
RCTs included, only one meta-analysis could be conducted. However, a forest plot
depicting depression outcomeson allmeasures employedwithin eachof the three RCTs is
provided.
Randomized controlled trials
Two of the included RCTs measured depression outcomes using two continuous
measures of depression (Chu et al., 2016: CDRS-R, Center for Epidemiologic Studies
Depression Scale [CES-D]; McCauley et al., 2015: CDRS-R, Short Mood and Feelings
Questionnaire [SMFQ]), whilst the third reported on three (Stark, 1985: CDRS-R,
Children’s Depression Inventory [CDI], Children’s Depression Scale [CDS]). A forest plot
was produced to provide a graphical display of these study outcomes (Figure 2). During
data extraction, it was noted that in one of the studies (Chu et al., 2016), there was a
baseline imbalance in depression severity scores (intervention 42.57 [SE 5.08], wait list
46.00 [SE 3.95]) and an error in the reporting of the standard error for the depression
severity scores post-intervention (wait list SE = 0; intervention SE = 5.36). Rather than
exclude this study from the analysis, it was decided to use the reported estimates and
standard errors from the adjusted models (including adjustments for baseline scores) to
ensure inappropriately large differences were not attributed to the intervention.
All threeRCTsmeasured depression using theCDRS-R and demonstrated reductions in
depression scores using this measure. McCauley et al. (2015) reported that mean CDRS-R
scores between pre-treatment and end of treatment reduced from57.6 (SD: 11.8) to 40.18
(SD: 13.9) for those receiving BA in comparison with a reduction from 57.8 (SD: 8.3) to
45.05 (SD: 14.2) for those receiving treatment as usual. At end of treatment, 76% of
participants randomized to BA scored forty or below on the CDRS-R, indicating a
depression diagnosis to be either ‘possible’ or ‘unlikely’ in comparison with 42% of those
receiving treatment as usual. These pre-treatment to end-of-treatment outcomes fell
within the 95% confidence interval suggesting reliability in the change scores. In the study
by Chu et al. (2016), CDRS-R depression scores reduced from 42.6 (SD: 5.08) to 37.67
(SD: 5.36) from pre-treatment to post-treatment in the BA group, whilst scores increased
from 46.0 (SD: 3.95; pre-wait list) to 57.0 (SD: 0.00; post-wait list) in the control group.
Owing to the small sample size employed within this study, statistical analyses were not
performed, and therefore, the significance of these results cannot be inferred. Finally,
Stark (1985) reported reductions in mean CDRS-R depression scores for those receiving
BA to be from 33.50 (SD: 10.27) at pre-treatment to 24.02 (SD: 6.01) at end of treatment
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and then to 24.28 (SD: 4.68) at follow-up. For those receiving self-control therapy, mean
CDRS-R scores reduced from37.22 (SD: 8.36) at pre-treatment to 22.90 (SD: 4.36) at endof
treatment and to 20.69 (SD: 3.45) at follow-up. Reductions in the wait list group reduced
from27.57 (SD: 3.51) at pre-treatment to 27.24 (SD: 5.74) at end of treatment and to 22.60
(SD: 5.03) at follow-up. However, the results of an ANCOVA test demonstrated that the
difference between groups on the CDRS-R at end of treatment was not significant
(p < .30).
As the included RCTs were judged to be sufficiently similar, a meta-analysis was
conducted for the CDRS-R. The effect of BA on CDRS-R depression scores was moderate
with a pooled mean difference of 4.17 (95% CI: 8.25, 0.09; Figure 3). This
demonstrates a statistically significant difference in CDRS-R scores in favour of BA. The I2
statistic was 0% (p = .926) suggesting no statistical heterogeneity was present (Higgins
et al., 2003).
In relation to the other depression measures, in the study by Stark (1985), mean
depression scores as measured by the CDI reduced in the BA group from 22.40 (SD: 8.47)
at pre-treatment to 9.11 (SD: 8.32) at end of treatment and to 7.43 (SD: 7.23) at follow-up.
In the self-control therapy, mean CDI scores reduced from 21.60 (SD: 5.48) at pre-
treatment to 8.09 (SD: 6.65) at end of treatment and to 5.36 (SD: 5.04) at follow-up, whilst
Chu et al. (2016)
CDRS-R
CES-D
McCauley et al. (2015)
CDRS-R
SMFQ
Stark (1985)
CDRS-R
CDI
CDS
ID
Study
–5.64 (–17.42, 6.14)
–2.69 (–10.33, 4.95)
–4.90 (–13.61, 3.81)
–0.20 (–4.43, 4.03)
–3.52 (–8.81, 1.77)
–10.34 (–18.82, –1.86)
–7.37 (–16.24, 1.50)
ES (95% CI)
–18.8 0 18.8
Favours intervention                                  Favours control
All depression measures
Figure 2. Forest plot of all depression measures across included randomized controlled trials (n = 3).
16 Lucy Tindall et al.
scores in the wait list control group reduced from 20.00 (SD: 10.71) at pre-treatment to
19.45 (SD: 10.31) at end of treatment and then to 7.40 (SD: 5.68) at follow-up. The results
of an ANCOVA test demonstrated that these between-group differences were statistically
significant (p < .01) at the end of treatment. Thus, those receiving treatment had a greater
reduction in depression scores, at this point than those in the wait list control group.
In the same study (Stark, 1985), mean depression scores as measured by the CDS
also reduced in the BA group from 71.10 (SD: 10.38) at pre-treatment to 55.24 (SD:
12.18) at end of treatment and to 50.03 (SD: 13.23) at follow-up. In the self-control
therapy group, CDS scores reduced from 72.40 (SD: 10.31) at pre-treatment to 50.29
(SD: 8.63) at end of treatment and then further reduced to 46.46 (SD: 8.31) at follow-
up. For the wait list group, mean CDS scores reduced from 66.00 (SD: 18.80) at pre-
treatment to 62.61 (SD: 7.14) at end of treatment and then to 48.20 (SD: 13.29) at
follow-up. These differences, however, fell short of conventional levels of statistical
significance (p < .07).
On the CES-D in the study by Chu et al. (2016), rates of depression reduced in the BA
group from 21.00 (SD: 2.15) to 16.38 (SD: 2.30) compared to a reduction from 20.22 (SD:
2.73) to 19.07 (SD: 3.15) in the wait list group. However, once again statistical tests were
not performed due to a small sample size and lack of control.
The final continuous measure used within the three RCTs was the SMFQ. In the BA
group, mean scores reduced from 16.1 (SD: 6.1) at pre-treatment to 6.3 (SD: 7.4) at end of
treatment in comparison with a reduction from 15.6 (SD: 6.2) at pre-treatment to 6.5 (SD:
6.5) at end of treatment in the treatment as usual group. These differences in groupswere,
however, not significant (p = .53).
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.926)
Stark (1985)
ID
McCauley et al., (2015)
Chu et al., (2016)
Study
–4.17 (–8.25, –0.09)
–3.52 (–8.81, 1.77)
ES (95% CI)
–4.90 (–12.55, 2.75)
–5.64 (–17.42, 6.14)
–17.4 0 17.4
Favours intervention                                 Favours control
CDRS-R Depression measure
Figure 3. Random-effects meta-analysis of the CDRS-R across included randomized controlled trials
(n = 3).
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In addition to the continuousmeasures reported,McCauley et al. (2015) conducted the
Kiddie Schedule for Affective Disorders (K-SADS) diagnostic interview with participants.
Results demonstrated that 77% of BA participants no longer met diagnostic criteria for
depression at end of treatment compared to 25% in the treatment as usual group.
Within-participant designs
In thewithin-participant design studies, two studies (Douleh, 2013; Riley&Gaynor, 2014)
employed a stepped-care approach, whilst the remainder (Chu et al., 2009; Jacob et al.,
2013; Ritschel et al., 2011; Wallis et al., 2012; Weersing et al., 2008) conducted case
series studies.
In the study byRiley andGaynor (2014), all participants received non-directive therapy
(NDT) and, if not demonstrating improved depression ratings, subsequently received BA.
Of those who received BA, 57% demonstrated a clinically significant change on both the
CDRS-R and the CDI at the end of treatment. There were also significant differences on
both measures from post-NDT to post-BA (CDRS-R: M = 41.57 [11.79]: Z = 2.37,
p = .02; CDI: M = 16.29 [10.24]: Z = 2.37, p = .02).
All participants in the study by Douleh (2013) receivedmotivational interviewing (MI)
followed by fun activity (FA) sessions if not demonstrating reductions in depression
ratings and subsequently BA (values-based behavioural activation) if depression was still
evident after both MI and FA. Overall, only one participant in this study received BA. For
this participant, depression scores on the CDRS-R reduced from 53 at baseline to 31 post-
BA and 25 at follow-up. Reductions on the Beck Depression Inventory (BDI-II) were also
reported, reducing from 31 at baseline to 14 post-BA, and to 11 at follow-up.
In all within-participant designs employing a case series methodology, reductions in
depression scores were evident following BA. Jacob et al. (2013) andWallis et al. (2012)
reported reduced scores on the BDI-II for all participants from baseline to trial completion
with the participants in the latter of these two studies attaining depressive scores in the
‘normal’ range on this measure. Jacob et al. (2013) also reported reductions in depressive
scores on the CDRS-R and the K-SADSwith 2/3 participants no longer meeting the criteria
of a depressive disorder following BA. Similarly, Ritschel et al. (2011) reported significant
reductions in depressive scores as measured by both the BDI-II and the CDRS-R with 66%
of participants being in the ‘normal’ range following treatment completion and thus
similar to a non-clinical sample. In the study by Weersing et al. (2008), both participants
demonstrated a decrease in depression scores on the CDI from baseline to six-month
follow-up, whilst Chu et al. (2009) reported significant reductions in depression scores
on the CES-D for 2/5 participants. All reported results for the within-participant design
studies can be seen in Table 5.
BA effectiveness and other outcomes
Besides depression, this review also sought to examine the effectiveness of BA and several
additional outcomes of interest. These were levels of anxiety symptoms, cost-
effectiveness, quality of life, and school attendance.
Randomized controlled trials
All three RCTs examined the effectiveness of BA in the treatment of anxiety. Chu et al.
(2016) reported greater reductions in anxiety scores for those receiving BA (29.67 [SD:
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2.23] to 21.05 [SD: 2.41]) compared to those in the wait list group (28.51 [SD: 3.36] to
26.93 [SD: 4.56]) from pre- to post-treatment as measured by the Screen for Anxiety
Related Emotional Disorders (SCARED). Once again owing to the small sample size
employed within this study, statistical analyses were not performed, and therefore, the
significance of these results cannot be inferred. Finally, using the Revised Children’s
Manifest Anxiety Scale, Stark (1985) reported statistically significant reductions in anxiety
from pre- to post-testing in those receiving either BA or self-control therapy (p < .01) and
no improvement for those in thewait list condition. Individuals who received self-control
therapy demonstrated the highest reductions in anxiety at post-testing.
None of the included RCTs reported on the cost-effectiveness of BA nor on its impact
on quality of life or school attendance.
Within-participant designs
Of the sevenwithin-participant design studies, two reported on the effectiveness of BA for
treating anxiety (Chu et al., 2009; Weersing et al., 2008). Based on the SCARED, both
participants in the study by Weersing et al. (2008) demonstrated reduced anxiety scores
following BA. For one participant, anxiety scores reduced across all time points following
treatment completion; however, for the other, anxiety scores had increased again by six-
month follow-up. In the study by Chu et al. (2009), two of the five included participants
had reduced anxiety scores, as measured by the MASC, following BA. For the remaining
three, one saw an increase in their anxiety score, for one it remained the same, whilst the
other withdrew from treatment and did not complete follow-up measures.
Only one included study (Riley&Gaynor, 2014) examined BA and quality of life. Using
the Family Quality of Life Scale–Family Interactions Subscale, a significant increase in
quality of life was found by the conclusion of BA (M = 21.29 [7.68]: Z = 2.21, p = .03).
Table 5. Within-participant design studies table of results
Study Measure
Pre-treatment
Mean (SD) n
Post-treatment
Mean (SD) n
Follow-up
Mean (SD) n
Riley and Gaynor
(2014)
CDRS-R 55.36 (12.36) n = 11 41.57 (11.79) n = 7 –
CDI 22.73 (9.29) n = 11 16.29 (10.24) n = 7 –
FQOLS 17.14 (6.04) n = 11 21.29 (7.68) n = 7 –
Douleh (2013) CDRS-R 58.79 (9.11) n = 14 31 n = 1 25 n = 1a
BDI-II 21(11.48) n = 14 14 n = 1 11 n = 1a
Ritschel et al. (2011) CDRS-R 57.67 (11.18) n = 6 27.67 (8.07) n = 5 N/A
BDI-II 28.00 (6.51) n = 6 6.00 (5.87) n = 5 N/A
Chu et al. (2009) CES-D 36.80 (6.22) n = 5 32.25 (14.39) n = 4 N/A
MASC 51.40 (13.37) n = 5 50.00 (19.13) n = 4 N/A
Wallis et al. (2012)b BDI-II 25 (10.22) n = 5 12.2 (7.79) n = 5 N/A
Weersing et al.
(2008)b
CDI 23 (2) n = 2 9.5 (1.5) n = 2 4 (2) n = 2c
SCARED 32.5 (11.5) n = 2 13 (10) n = 2 8.5 (8.5) n = 2c
Jacob et al. (2013) CDRS-R 59.3 (13.6) n = 3 33.0 (19.1) n = 3 N/A
BDI-II 21.7 (4.1) n = 3 4.0 (2.0) n = 3 N/A
aFollow-up at 20 weeks.
bResults not available therefore scores estimated from figures presented within the study papers,
– incomplete data reported.
cFollow-up at 24 weeks.
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None of the included within-participant designs reported on the cost-effectiveness of BA
nor on its impact on school attendance.
Computerized BA
Although the ten studies included within this review provided information regarding the
effectiveness of BA for youngpeoplewith depression, noneof the studies deliveredBA in a
computerized form. Therefore, the second objective of this review: whether BA can be
effectively delivered in a computerized form, could not be investigated. Furthermore,
none of the studies reported on the impact of BA on school attendance or investigated the
cost-effectiveness of the treatment – the remaining secondary outcomes specified.
Discussion
This systematic review aimed to assess the effectiveness of BA in the treatment of
adolescents with depression and investigate whether BA delivered in a computerized
form is effective within this treatment context.
Across all included studies, regardless of methodology, reductions in depression were
evident following BA. At the individual level, several of the findings were statistically
significant, and when the RCT studies were combined within the meta-analysis, a
statistically significant difference in CDRS-R scores from pre- to post-treatment was found
in favour of BA.
The findings of this review provide some preliminary evidence that BA may be an
effective treatment of depression in young people. Not only were reductions in
depression scores reported following BA across studies, within the RCTs these reductions
were greater in comparison with those randomized to a control group. These findings are
similar to those previously reported in adult studies where BA has been found to be
superior to control conditions (e.g., Ekers et al., 2008; Mazzuchelli et al., 2009).
Besides depression, several of the included studies examined the effectiveness of BA
on two of the secondary outcome measures – anxiety and quality of life. Five of the
included studies (Chu et al., 2016; McCauley et al., 2015; Stark, 1985; Chu et al., 2009;
Weersing et al., 2008) measured anxiety scores with all reporting reductions following
BA. In relation to quality of life, in the one study that reported on it (Riley&Gaynor, 2014),
there was a significant increase found by the conclusion of BA. These findings provide
preliminary evidence that BA may also be effective in reducing anxiety and increasing
quality of life for young people experiencing depression.
The second aim of this systematic reviewwas to investigate whether BA delivered in a
computerized form is effective in the treatment of young peoplewith depression. Despite
research suggesting the effectiveness of computer-delivered therapies for young people
(e.g., Merry et al., 2012; Stallard et al., 2010), none of the ten included studies delivered
BA in a computerized form, and therefore, this aim could not be addressed. In addition,
none examined the impact of BA on school attendance or investigated the cost-
effectiveness of the treatment.
Limitations
Although this review has generated important information relating to the effectiveness of
BA in the treatment of depression in young people, a number of methodological
limitations need to be considered when interpreting the findings.
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Firstly, as only three RCTs were included within the review, only one meta-analysis
could be completed. Although a pooledmean difference could be calculated and supports
the effectiveness of BA for the treatment of depression, the results need to be interpreted
with caution. The discrepancies noted with one of the included RCTs (Chu et al., 2016)
and the subsequent adjustmentmademay have impacted upon the accuracy of the results
reported. In addition, through the inclusion of only three studies in the meta-analysis,
explorations of publication bias could not be conducted.
The methodological flaws identified in all included studies may also have impacted
upon the results presented. For example, a number of studies (e.g., Chu et al., 2016;
Stark, 1985) provided no information regarding allocation concealment which may have
inflated the effect sizes in favour of positive results (Shulz & Grimes, 2002; Wood et al.,
2008). As several studies (e.g., Chu et al., 2009; Jacob et al., 2013) did not conduct any
statistical analyses, their findings could only be inferred. In addition, the sample sizes of
the included studies were low with the maximum number recruited in any study being
60 (McCauley et al., 2015). It must be noted that this was the only study to employ
power calculations. Therefore, it is unclear whether the other two RCTs or within-
participant design studies recruited sufficient numbers of participants to identify an
intervention effect.
In two of the studies, a transdiagnostic approach was taken (Chu et al., 2009;
Weersing et al., 2008) whereby BA was used to treat both depression and anxiety.
Although there is often comorbidity between anxiety and depression and so it was added
within this review as a secondary outcome, the primary focus was on the effectiveness of
BA for treating depression. Thus, itmay be hard to distinguish between the elements of BA
effective for treating depression and those for anxiety within these studies as the two are
reported collectively.
Finally, no information was supplied in any of the studies about delivery of BA in a
computerized form nor on the additional outcomes under review (school attendance,
cost-effectiveness). These were deemed as important factors at inception of the review
but unfortunately cannot be reported on.
Conclusions
This review was conducted to examine the effectiveness of BA for treating young people
with depression. Ten studies (three RCTs and seven within-participant designs) met the
inclusion criteria and were subsequently included. The results provided some initial
evidence that BA may be an effective treatment of depression in young people.
A number of methodological constraints in the included studies mean that the results
need to be interpreted with caution. Such constraints need to be addressed in any future
research.
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Appendix : Search strategy
1. Behavio* activation.ti,ab.
2. (behavio* adj2 (intervention* or therap* or treatment* or psychotherap* or psycho-
therap*)).ti,ab.
3. Behavior Therapy/
4. Cognitive Therapy/
5. self monitor*.ti,ab.
6. (Activit* adj3 (schedul* or plan* or arrang* or organis* or organiz*)).ti,ab.
7. 1 or 2 or 3 or 4 or 5 and 6
8. Depression/
9. exp Depressive Disorder/
10. Depression.ti,ab.
11. Depressive.ti,ab.
12. Depressed.ti,ab.
13. ((low or negative or decreas*) adj2 (mood* or affect)).ti,ab.
14. 8 or 9 or 10 or 11 or 12 or 13
15. 7 and 14
16. young people.ti,ab.
17. young person*.ti,ab.
18. (child* or schoolchild*).ti,ab.
19. teen*.ti,ab.
20. adoles*.ti,ab.
21. youth*.ti,ab.
22. student*.ti,ab.
23. juvenile*.ti,ab.
24. pre-pubert*.ti,ab.
25. (pre-pubert* or prepubert*).ti,ab.
26. (pre-pubescen* or prepubescen*).ti,ab.
27. (pre-teen* or preteen*).ti,ab.
28. (puberty or pubertal).ti,ab.
29. Child/
30. Adolescent/
31. 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30
32. 7 and 14 and 31
33. exp animals/ not humans.sh.
34. 32 not 33
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